Clinical Trials
2 trialsNCT01752023 2018-10-17
NA_00067809
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT00701558 2016-06-24
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 2 Completed